Avantor | Jotup

Ashland Board appoints Ashish K. Kulkarni as new director

Retrieved on:

Mercredi, mai 8, 2024

Safety, ROI, Celanese, Ashland Global, General Electric, Policy, GAF, Biophysical environment, Retirement, Avantor, United Technologies, Management

WILMINGTON, Del., May 08, 2024 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH) is announcing the appointment of Ashish K. Kulkarni to its Board of Directors.

Key Points:

WILMINGTON, Del., May 08, 2024 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH) is announcing the appointment of Ashish K. Kulkarni to its Board of Directors.
Kulkarni is the CEO of Kebotix, a startup company focused on commercializing artificial intelligence methods into new material commercialization.
With the addition of Kulkarni and in anticipation of potential director retirements under the Board’s retirement and resignation policy, Ashland increases the size of the Board to 11 members.
“I am pleased to welcome Ashish as a new director to the Ashland Board,” said Guillermo Novo, chair and chief executive officer, Ashland.

Avantor® to Participate in BofA Securities 2024 Health Care Conference

Retrieved on:

Vendredi, mai 3, 2024

Bank of America, AVTR, BofA Securities, Avantor, Webcast, Conference

RADNOR, Pa., May 3, 2024 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technologies industries, announced that Michael Stubblefield, President and CEO, will be participating in a fireside chat at the BofA Securities 2024 Health Care Conference in Las Vegas on Tuesday, May 14, 2024 at approximately 10:00 a.m. Pacific Time.

Key Points:

RADNOR, Pa., May 3, 2024 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technologies industries, announced that Michael Stubblefield, President and CEO, will be participating in a fireside chat at the BofA Securities 2024 Health Care Conference in Las Vegas on Tuesday, May 14, 2024 at approximately 10:00 a.m. Pacific Time.
To hear a live audio webcast of the session, visit Events & Presentations in the Investor section of Avantor's website, ir.avantorsciences.com .
A replay of the webcast will be available for 30 days.

Telesis Bio Inc. announces strategic focus on game-changing Gibson SOLA enzymatic DNA synthesis (EDS) platform and BioXp mRNA solutions and announces new leadership

Retrieved on:

Jeudi, avril 18, 2024

EDS, 9600, Doctor of Philosophy, Growth, Entrepreneurship, Automation, Avantor, DNA, Messenger, Drug discovery, SAN, Gene, Telesis

SAN DIEGO, April 18, 2024 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), a leader in automated benchtop DNA and mRNA synthesis solutions, today announced a focus in strategy enabled by the commercial availability of its groundbreaking Gibson SOLA platform.

Key Points:

SAN DIEGO, April 18, 2024 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), a leader in automated benchtop DNA and mRNA synthesis solutions, today announced a focus in strategy enabled by the commercial availability of its groundbreaking Gibson SOLA platform.
“We believe our advances in enzymatic synthesis will ultimately accelerate the current drug discovery paradigm by creating mRNA-based vaccine and therapeutic candidates in days rather than weeks or months,” said Dan Gibson, PhD, Co-Founder of Telesis Bio.
Gibson SOLA can deliver on-demand DNA and mRNA in 1 – 2 days, enabling high throughput production at near 100% fidelity in unprecedented time.
Expanded the BioXp selling channel to broaden reach and provide easier access to its advanced benchtop synthesis technology.

Avantor® Reports First Quarter 2024 Results

Retrieved on:

Vendredi, avril 26, 2024

AVTR, Avantor, Adjustment, GAAP, EPS

We are reaffirming fiscal year 2024 guidance and remain focused on executing our long-term growth strategy," Stubblefield concluded.

Key Points:

We are reaffirming fiscal year 2024 guidance and remain focused on executing our long-term growth strategy," Stubblefield concluded.
For the three months ended March 31, 2024, net sales were $1.68 billion, a decrease of 5.6% compared to the first quarter of 2023.
Net sales were $1,157 million, a reported decrease of 3.8%, as compared to $1,203 million in the first quarter of 2023.
We will host a conference call to discuss our results today, April 26, 2024, at 8:00 a.m. Eastern Time.

BeautyHealth Names Sheri Lewis as Chief Supply Chain and Operations Officer

Retrieved on:

Mardi, avril 9, 2024

Supply Chain Management, Luxury, Cosmetics, Retail, Specialty, SKIN, Concordia University, EVP, Avantor, History, Honeywell, Medtronic, Management

The Beauty Health Company (NASDAQ: SKIN), home to flagship brand Hydrafacial, today announced that it has appointed Sheri Lewis as Chief Supply Chain and Operations Officer, effective immediately.

Key Points:

The Beauty Health Company (NASDAQ: SKIN), home to flagship brand Hydrafacial, today announced that it has appointed Sheri Lewis as Chief Supply Chain and Operations Officer, effective immediately.
Ms. Lewis will report to BeautyHealth’s President and Chief Executive Officer, Marla Beck.
“Sheri is a talented and deeply experienced executive who brings decades of valuable global operations expertise to BeautyHealth as we chart the future of the Company,” said Marla Beck, BeautyHealth President and Chief Executive Officer.
Most recently, Ms. Lewis was the EVP of global supply chain operations at Avantor, Inc., where she served on the executive committee and led the company’s global integrated supply chain strategy and operational performance with oversight of over 3,500 associates.

Avantor® to Host First Quarter 2024 Earnings Call on Friday, April 26, 2024

Retrieved on:

Lundi, avril 1, 2024

Avantor, AVTR, Webcast

RADNOR, Pa., April 1, 2024 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, announced that it will release its first quarter 2024 financial results before the market opens on Friday, April 26, and will hold a conference call on the same day at 8:00 a.m. Eastern Time to discuss the results.

Key Points:

RADNOR, Pa., April 1, 2024 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, announced that it will release its first quarter 2024 financial results before the market opens on Friday, April 26, and will hold a conference call on the same day at 8:00 a.m. Eastern Time to discuss the results.
To hear a live audio webcast of the session, visit Events & Presentations in the Investor section of Avantor's website, ir.avantorsciences.com .
A replay of the webcast will be available for 30 days.

Avantor® Celebrates Supplier Award Honorees at 2024 European Sales Conference

Retrieved on:

Lundi, février 26, 2024

Avantor, Marketing, AVTR, Supplier, International organization, Conference

The event brought together Avantor's European sales organization and the Company's supplier partners and focused on collaboration to deliver an exceptional customer experience.

Key Points:

The event brought together Avantor's European sales organization and the Company's supplier partners and focused on collaboration to deliver an exceptional customer experience.
As part of the event, the Avantor Supplier Award honorees were celebrated for distinguished product quality, collaboration, operational excellence, marketing, and overall performance.
"The European Sales Conference is a valuable opportunity to connect with our supplier partners who play a crucial role from discovery to delivery in providing choice and innovation to our customers.
The European sales organization selected BINDER GmbH as the Supplier of the Year for 2024.

Avantor® to Participate in the 44th Annual TD Cowen Health Care Conference

Retrieved on:

Mardi, février 20, 2024

AVTR, Avantor, Webcast, Conference

RADNOR, Pa., Feb. 20, 2024 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, announced that Michael Stubblefield, President and CEO, will participate in a fireside chat at the 44th Annual TD Cowen Health Care Conference in Boston on Tuesday, March 5, 2024, at approximately 10:30 a.m. Eastern Standard Time.

Key Points:

RADNOR, Pa., Feb. 20, 2024 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, announced that Michael Stubblefield, President and CEO, will participate in a fireside chat at the 44th Annual TD Cowen Health Care Conference in Boston on Tuesday, March 5, 2024, at approximately 10:30 a.m. Eastern Standard Time.
To hear a live audio webcast of the session, visit Events & Presentations in the Investor section of Avantor's website, ir.avantorsciences.com .
A replay of the webcast will be available for 30 days.

Avantor® Reports Fourth Quarter and Full Year 2023 Results

Retrieved on:

Mercredi, février 14, 2024

AVTR, Growth, EPS, Avantor, GAAP, COVID-19, Adjustment

RADNOR, Pa., Feb. 14, 2024 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, today reported financial results for the fourth quarter and year ended December 31, 2023.

Key Points:

For the three months ended December 31, 2023, net sales were $1.72 billion, a decrease of 4.0% compared to the fourth quarter of 2022.
Net sales were $994.8 million, a reported decrease of 5.1%, as compared to $1,048.0 million in the fourth quarter of 2022.
Net sales were $603.5 million, a reported decrease of 2.2%, as compared to $617.2 million in the fourth quarter of 2022.
Net sales were $124.5 million, a reported decrease of 4.1%, as compared to $129.8 million in the fourth quarter of 2022.

Avantor® to Report Fourth Quarter and Full Year 2023 Earnings on Wednesday, February 14, 2024

Retrieved on:

Mercredi, janvier 24, 2024

Avantor, AVTR, Webcast

RADNOR, Pa., Jan. 24, 2024 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, announced that it will release its fourth quarter and full year 2023 financial results before the market opens on Wednesday, February, 14, and will hold a conference call to discuss the results on the same day at 8:00 a.m. Eastern Standard Time.

Key Points:

RADNOR, Pa., Jan. 24, 2024 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, announced that it will release its fourth quarter and full year 2023 financial results before the market opens on Wednesday, February, 14, and will hold a conference call to discuss the results on the same day at 8:00 a.m. Eastern Standard Time.
To hear a live audio webcast of the session, visit Events & Presentations in the Investor section of Avantor's website, ir.avantorsciences.com .
A replay of the webcast will be available for 30 days.